NEW: Examine Personalized — easily keep up with the latest research. On sale
until tonight!
Learn more
| Effect | None |
| Trial Design | Double blind |
| Trial Length | n/a |
| Number of Subjects | 63 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Obese |
In diabetic persons with 10-12 years of diabetes who failed to respond to ACE inhibitors or ARB therapy who were given 900mg benfotiamine (3x300mg) for 12 weeks failed to find any significant benefit of supplementation.
